StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.19+0.00 (+1.30%)

Close on Nov 17, 2026Market cap $2.39MP/E –Yield –

20/20 Biolabs gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 29.6%, against 20.6% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202529.6%+9.0
FY2024Dec 31, 202420.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202641.7%–
Q1 FY2026Mar 31, 202617.8%–
Q2 FY2025Jun 30, 202530.5%–
Q1 FY2025Mar 31, 202529.9%–

More 20/20 Biolabs figures

See a number that looks wrong?